HBV-и HCV-инфекции у больных, получающих лечение программным гемодиализом; алгоритм вакцинопрофилактики гепатита В при хронической почечной недостаточности
Диссертация
Широта распространения и формирование очагов HBVи HCV-инфекций в отделениях гемодиализа, ухудшение результатов заместительной почечной терапии и качества жизни больных, а также рост материальных затрат, связанных с инфицированием, определяют актуальность этой проблемы для практического здравоохранения и, в частности, для клинической нефрологии. Тем не менее многие вопросы эпидемиологии, клиники… Читать ещё >
Содержание
- ГЛАВА I. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. Распространенность HBV- и HCV-инфекций и пути заражения в отделениях гемодиализа
- 1. 2. Клинические особенности HBV- и HCV-инфекций у больных, получающих лечение ПГД
- 1. 3. Механизмы противовирусного иммунитета и особенности иммунных нарушений при ХПН
- 1. 4. Вакцинопрофилактика гепатита В у больных на гемодиализе
- 1. 5. Факторы, влияющие на результаты вакцинации против гепатита В у пациентов, получающих лечение гемодиализом
- 1. 6. Новые подходы к вакцинопрофилактике гепатита В в условиях лечения ПГД
- СОБСТВЕННЫЕ ИССЛЕДОВАНИЯ
- ГЛАВА II. МАТЕРИАЛЫ И МЕТОДЫ ИССЛЕДОВАНИЯ
- 2. 1. Характеристика наблюдавшихся больных
- 2. 2. Методы исследования
- ГЛАВА III. КЛИНИКО-ЭПИДЕМИОЛОГИЧЕСКАЯ ХАРАКТЕРИСТИКА
- HBV- и НСУ-ИНФЕКЦИЙ У ПАЦИЕНТОВ С тХПН в
- УСЛОВИЯХ ЛЕЧЕНИЯ ПГД
- 3. 1. Эпидемиологическая характеристика
- 3. 2. Клиническая характеристика
- 3. 3. Морфологическая характеристика
- ГЛАВА IV. РЕЗУЛЬТАТЫ ВАКЦИНОПРОФИЛАКТИКИ ГЕПАТИТА В ПРИ ХПН
- 4. 1. Вакцинация больных с ддХПН
- 4. 2. Вакцинация больных с тХПН, получавших лечение ПГД
- 4. 3. Осложнения вакцинации
- 4. 4. Инфицирование HBV в условиях вакцинации
- 4. 5. Отдаленные результаты вакцинопрофилактики гепатита В- возможные сроки ревакцинации
- ГЛАВА V. ПРЕДИКТОРЫ НИЗКОЙ ЭФФЕКТИВНОСТИ ВАКЦИНОПРОФИЛАКТИКИ ГЕПАТИТА В У БОЛЬНЫХ НА ГЕМОДИАЛИЗЕ
- 5. 1. Предикторы низкой эффективности промежуточных к 3-му месяцу) результатов вакцинации
- 5. 2. Предикторы низкой эффективности окончательных к 7-му месяцу) результатов вакцинации
- ГЛАВА VI. ПРИМЕНЕНИЕ НЕСТАНДАРТНЫХ МЕТОДОВ ВАКЦИНАЦИИ ПРОТИВ ГЕПАТИТА В У ПАЦИЕНТОВ, ПОЛУЧАВШИХ ЛЕЧЕНИЕ ПГД- АЛГОРИТМ ВАКЦИНОПРОФИЛАКТИКИ ПРИ ХПН
- 6. 1. Вакцинация против гепатита В больных с «изолированными» анти-НВс
- 6. 2. Внутрикожная дробная вакцинация
- 6. 3. Вакцинация с предварительным введением колониести-мулирующего фактора гранулоцитов-макрофагов (лейкомакс)
- 6. 4. Алгоритм вакцинопрофилактики гепатита В при ХПН
Список литературы
- Акимкин В.Г., Скворцов С. В., Лыцарь В. Н. и др. Эпидемиологические особенности распространения вирусных гепатитов В и С среди пациентов отделения гемодиализа // Гепатит С (Российский консенсус): Тез. докл. науч.-практ. конф. М., 2000. — С. 4−5.
- Ермоленко В.М. Хронический гемодиализ. М.: Медицина, 1987. — С. 218−140.
- Ивашкин В.Т., Калинин А. В., Ивлев А. С. и др. Распространенность вирусных гепатитов В и С среди доноров крови, больных и медицинского персонала. // Рос. журнал гастроэнтерол., гепатол., колопроктол. 1993. — T. XI, № 2. — С. 34−38.
- Костерева Е.М., Васильев А. Н., Михайлов А. А. и др. Проблемы вакцинации больных с хронической почечной недостаточностью, получающих лечение гемодиализом // Нефрология. 2003. — № 1. — С. 102−105.
- Кузин С.Н. Сравнительная эпидемиологическая характеристика гепатитов с парентеральным механизмом передачи возбудителей в России и других странах СНГ: Автореф. дис. докт. мед. наук. -М., 1998. 52 с.
- Лисицина Е.В. Распространение НС-вирусной инфекции и отдельных генотипов вируса гепатита С в регионах с умеренной активностью эпидемического процесса: Автореф. дис. канд. мед. наук. -М., 1998.-31 с.
- Львов Д.К., Миширо С., Селиванов Н. А. и др. Распространение генотипов вируса гепатита С, циркулирующих на территории Северо-Западной и Центральной частей России // Вопр. вирусол. 1995. — № 6. — С. 251−253.
- Львов Д.К., Самохвалов Е. И., Миширо С. и др. Закономерности распространения вируса гепатита С и его генотипов в России и странах СНГ // Вопр. вирусол. 1997. — № 4. — С. 17−161.
- Михайлов М.И., Шахгильдян И. В., Есаулкова А. Ю. и др. Гепатит В -предварительный скрининг // Уральское медицинское обозрение. Тематическое приложение. 1998. — № 1. — С. 19−21.
- Мукомолов C.JI. Вирусный гепатит С. Клинико-эпидемиологическая и лабораторная характеристика: Автореф. дис.. докт. мед. наук. СПб, 1994.-35 с.
- Назаров Ш. Н., Акалаев Р. Н., Арипходжаева Ф. А., Миркамалов А. А. Проблемы вирусного гепатита в отделениях гемодиализа // Журнал микро-биол., эпидемиол., иммунол. 1993. — № 2. — С. 71−73.
- Новиков Д.К. Справочник по клинической иммунологии и аллергологии. Мн.: Беларусь, 1987. — 223 с.
- Онищенко Г. Г., Шахгильдян И. В. Актуальные вопросы эпидемиологии и профилактики вирусных гепатитов В и С в Российской Федерации // Журнал микробиол., эпидемиол., иммунол. 2000. — № 1. — С. 50−54.
- Савельев С.И., Ходякова И. А., Щукина И. А. и др. Инфицированность вирусами гепатитов В и С пациентов отделений гемодиализа // Гепатит В, С и Д проблемы диагностики лечения и профилактики: Тез. докл. IV Рос. науч.-практ. конф. — М., 2001. — С. 302−303.
- Савин Е.А. Широта распространения маркеров гепатита В и С в группах высокого риска инфицирования и вакцинопрофилактика среди них НВ-вирусной инфекции: Автореф. дис. канд. мед. наук. М., 1992. — 32 с.
- Савин Е.А., Кузин С. Н., Васильев А. Н. и др. Особенности профилактики НВ-вирусной инфекции в отделениях гемодиализа // Терапевтический архив. 1995. — № 2. — С. 47−51.
- Савин Е.А. Вирусные гепатиты (частные аспекты проблемы). СПб: Наука, 1996. — 191 с.
- Соринсон С.Н. Вирусные гепатиты А, В, С, D, Е, ни А-Е в клинической практике. СПб: Теза, 1996. — С. 48−66.
- Сычев А.В., Михайлов М. И. Инфицирование вирусом гепатита С медицинских работников и пациентов гемодиализных отделений Москвы // Вопр. вирусол. 1993. — № 3. — С. 105−107.
- Тареев Е.М., Ермоленко В. М., Ананьев В. А. и др. Вирусные гепатиты у больных, находящихся на поддерживающем ГД. Особенности клиники // Вопросы эпидемиологии. 1979. — № 4. — С. 20−26.
- Шахгильдян И.В., Онищенко Г. Г., Хухлович П. А. и др. Итоги изучения и нерешенные вопросы эпидемиологии и профилактики парентеральных вирусных гепатитов в России // Журнал микробиол., эпидемиол., имму-нол. 1994. — № 5. — С. 26−32.
- Шахгильдян И.В., Хухлович П. А., Савин Е. А. и др. Риск инфицирования вирусами гепатитов В и С медицинских работников, больных отделений гемодиализа и вакцинопрофилактики среди них НВ-вирусной инфекции // Вопр. вирусол. 1994. — № 5. — С. 226−229.
- Шахгильдян И.В., Михайлов М. И., Оиищеико Г. Г. Парентеральные вирусные гепатиты (эпидемиология, диагностика, профилактика). — М.: ГОУ ВУНМЦ МЗ РФ, 2003. С. 291−292.
- Abbas N., Bailey E., Gibson S.B. et al. The department of heals recommendations for hepatitis В vaccination are not effective in patients with chronic renal failure // XXXVI-th Congress ERA EDTA, 1999. Madrid, Spain. — P. 188.
- Agarwal S.K., Dash S.C., Irshad M. et al. Hepatitis С virus infection during haemodialysis in India // J. Assoc. Physicians India. 1999. — Vol. 47 (12). — P. 1139−1143.
- Alhababi F., Sallam T.A., Tong C.Y.W. The significance of 'anti-HBc only* in the clinical virology laboratoiy // J. Clin. Virol. 2003. — Vol. 27. — P. 162 169.
- Ambuhl P.M., Binswanger U., Renner E.L. et al. Epidemiology of chronic hepatitis В and С among dialysis patients in Switzerland // Schweiz. Med. Wo-chenschr. 2000. — Vol. 130 (10). — P. 341−348.
- Anandh U., Bastani В., Ballal S. et al. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis В vaccination in maintenance hemodialysis patients // Am. J. Nephrol. 2000. — Vol. 20 (1). — P. 53−56.
- Ando F.E. Overview of 5-year clinical experience with a yeast-derived hepatitis В vaccine // Vaccine. 1990. — Vol. 8 (suppl). — 74S-78S.
- Bailey G.L., Katz A.I., Hampers C.L., Merrill J.P. Alterations in serum enzymes in chronic renal failure // JAMA. 1970. — Vol. 213. — P. 2263−2265.
- Battels H., Bohmer M., Heierli C. et al. Serum creatinine determination without protein precipitation // Clin. Chim. Acta. 1972. — Vol. 37. — P. 193−197.
- Beaman M., Michael J., Maclennan I.C., Adu D. T cell independent and T cell dependent antibody response in patients with chronic renal failure // Nephrol. Dial. Transplant. 1989. — Vol. 4. — P. 216−221.
- Beasley R.P., Hwang L-Y., Lee QC-Y. et al. Prevention of perinatally transmitted hepatitis В virus infections with hepatitis В immune globulin and hepatitis В vaccine // Lancet. 1985. — ii. — P. 1099−1102.
- Beleed K., Wright M., Eadington D. et al. Vaccination against hepatitis В infection in patients with end stage renal disease // Postgrad. Med. J. 2002. -Vol. 78 (923).-P. 538−540.
- Benhamou E., Couroce A.M., Jangers P. et al. Hepatitis В vaccine: Randomized trial of immunogenicity in hemodialysis patients // Clin. Nephrol. -1984.-Vol. 21.-P. 143−147.
- Bergamini F., Zanetti A., Ferroni P. et al. Immune response to hepatitis В vaccine in staff and patients in renal dialysis units // J. Infect. 1983. — Vol. 7 (suppl. 1).-P. 35−40.
- Bergia R., Pellerey M., Berto I. et al. Hepatit В Vaccination in Uremic Patients: Comparison beetween Recombinant and Plasma-Derived Vaccine // Nephron. 1992. — Vol. 61. — P. 328.
- Bergmeyer H.U., Scheibe P., Wahlefeld A.W. Optimization of methods for aspartate aminotransferase and alanine aminotransferase // Clin. Chem. — 1978. -Vol. 24.-P. 58−73.
- Bernieh В., Allam M., Halepota A. et al. Prevalence of hepatitis С virus antibodies in hemodialysis patients in Madinah Al-Munawarah, Kingdom of Saudi Arabia // Saudi Med. J. 2003. — Vol. 24 (suppl. 2). — S125.
- Bock HL, Kruppenbacher J, Sanger R et al. Immunogenicity of a recombinant hepatitis В vaccine in adults. // Arch. Intern. Med. 1996. — Vol. 156. — P. 2226−2231.
- Boes M., Esau С., Fischer M.B. et al. Enhanced B-l cell development, but impaired IgG antibody responses in mice deficient in secreted IgM // J. Immunol. 1998. — Vol. 160. — P. 4776−4787.
- Bonino F., Recchia S., Farci P. et al. Hepatitis В virus replication and clinical outcome in carriers of HBsAg. Perspectives of treatment with DNA inhibitors // Liver. 1983. — Vol. 3(1).- P. 30−35.
- Bourqia A. Current status of treatment for chronic renal insufficiency in Morocco // Nephrologie. 1999. — Vol. 20. — P. 75−80.
- Busek S.U., Baba E.H., Tavares Filho H.A. et al. Hepatitis С and hepatitis В virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil // Mem. Inst. Oswaldo Cruz. 2002. — Vol. 97 (6). — P. 775−778.
- Butkowski В., Ciocalten A., Zavits J. et al. Evolution of renal replacement therapy Central and Eastern Europe 7 year after polical and economical liberation // Nephrol. Dial. Transplant. 1998. — Vol. 13. — P. 860−864.
- Cahen D.L., Van Leeuwen D.J., ten Kate F.J. et al. Do serum ALAT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis // Liver. 1996. — Vol. 16. — P. 105−109.
- Canero-Velasco M.C., Mutti J.E., Gonzalez J.E., et al. HCV and HBV prevalence in hemodialyzed pediatric patients. Multicenter study // Acta Gastroenterol. Latinoam. 1998. — Vol. 28 (3). — P. 265−268.
- Cappel R., Van Beers D., Liesnard C., Dratwa M, Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination // Nephron. 1983. — Vol. 33. — P. 21−25.
- Caramelo C., Navas S., Alberola M.L. et al. Evidence against transmission of hepatitis С virus through hemodialysis ultrafiltrate and peritoneal fluid // Nephron. 1994. — Vol. 66. — P. 470−473.
- Casciani C.U., de Simone C., Bonini S. et al. Immunological aspects of chronic uremia // Kidney Int. 1978. — Vol. 8. — S49-S54.
- Cendoroglo N.M., Manzano S.I., Canziani M.E. et al. Environmental transmission of hepatitis В and hepatitis С viruses within the hemodialysis unit // Artif. Organs. 1995. — Vol. 19 (3). — P. 251−255.
- Chadha M.S., Arankalle V.A. Ten-year serological follow up of hepatitis В vaccine recipients // Indian. J. Gastroenterol. 2000. — Vol. 19. — P. 168−171.
- Chan C.Y., Lee S.D., Tsai Y.T., Lo K.J. Hepatitis В vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc // J. Gastroenterol. Hepatol. 1995. — Vol. 10 (2). — P. 192−197.
- Chan T-M., Lau J.Y.N., Wu P-C. et al. Hepatitis С virus genotypes in patients on renal replacement therapy // Nephrol. Dial. Transplant. 1998. — Vol. 13. -P. 731−734.
- Chang P.C., Schrander-van der Meer A.M., van Dorp W.T. et al. Intracutaneous versus intramuscular hepatitis В vaccination in primary non-responding haemodialysis patients // Nephrol. Dial. Transplant. 1996. — Vol. 11 (1). — P. 191−193.
- Charest A.F., McDougall J., Goldstein MB. A randomized comparison of intradermal and intramuscular vaccination against hepatitis В virus in incident chronic hemodialysis patients // Am. J. Kidney Dis. 2000. — Vol. 36 (5). — P. 976−982.
- Charest A.F., Grand’Maison A., McDougall J., Goldstein M.B. Evolution of naturally acquired hepatitis В immunity in the long-term hemodialysis population // Am. J. Kidney Dis. 2003. — Vol. 42 (6). — P. 1193−1199.
- Chen K.S., Lo S.K., Lee N. et al. Superinfection with hepatitis С virus in hemodialysis patients with hepatitis В surface antigenemia: its prevalence and clinical significance in Taiwan // Nephron. 1996. — Vol. 73. — P. 158−164.
- Cheng C.H., Huang C.C., Leu N.L. et al. Hepatitis В vaccine in hemodialysis patients with hepatitis С viral infection // Vaccine. — 1997. Vol. 15(12−13).-P. 1353−1357.
- Chiaramonte М., Majori S., Ngatchu T. et al. Two different dosages of yeast derived recombinant hepatitis В vaccines: a cjmparison of immunogenicity // Vaccine. 1996.-Vol. 14.-P. 135−137.
- Chlabicz S., Grzeszczuk A., Lapinski T. Hepatitis В vaccine immunogenicity in patients with chronic HCV infection at on year follow-up: the effect of inter-feron-alpha therapy // Med. Sci Monit. 2002. — Vol. 8 (5). — P. 379−383.
- Chouaib S., Bertoglio J.H. Prostaglandin E as modulator of the immune response // Lymphokine Res. 1988. — Vol. 7. — P. 237−239.
- Cohen G.A., Goffinet J.A., Donabedian R.K., Conn H.O. Observations on decreased serum glutamic oxaloacetic transaminase (SGOT) activity in azotemic patients // Ann. Intern. Med. 1976. — Vol. 84. — P. 275−280.
- Colleoni N., Bucci R., Ribero M.L. et al. Hepatitis С virus genotype in anti-HCV-positive hemodialysis patients // Nephrol. Dial. Transplant. 1996. — Vol. 11.-P. 2258−2264.
- Colombo M., Choo Q-L., Del Ninno E. et al. Prevalence of antibodies to hepatitis С virus in Italian patients with hepatocellular carcinoma // Lancet. — 1989. -Vol. 334.-P. 1006−1009.
- Contin C., Pitard V., Delmas Y. et al. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients // Immunology. — 2003.-Vol. 110(1).- P. 131−140.
- Corouce A.M., Pillonell J. Viral Hepatitis Working Groups of the French Society of Blood Transfusion: transfusion transmitted viral infections // N. Engl. J. Med. — 1996. — Vol. 335. — P. 1609−1610.
- Coursaget P., Yvonnet В., Gilks W.R. et al. Scheduling of revaccination against hepatitis В virus // Lancet. 1991. — Vol. 337 (8751). — P. 1180−1183.
- Crosnier J., Jungers P., Courouce A-M. et al. Randomized placebo-controlled trial of hepatitis В surface antigen vaccine in French hemodialysis units // Lancet. 1981. — Vol. 1. — P. 455−459, P. 797−800.
- Crosnier J., Degos F., Jungers P. Dialysis associated hepatitis // In: Replacement of renal function by dialysis / Ed. Maher J.F. Dordrecht: Kluwer Academic, 1989.-P. 881−903.
- Crovari P., Cuneo-Crovari P., Icardi G.C. et al. Immunization of youhg adults with two yeast-derived hepatitis В vaccines // In: Viral hepatitis and liver disease / Ed. Zuckerman A.J. New York: Alan R Liss Inc., 1988. — P. 10 711 073.
- Dahl-Hansen E., Siebke J.C., Froland S.S., Degre M. Immunogenicity of yeast-derived hepatitis В vaccine from two different producers // Epidemiol. Infect. -1990.-Vol. 104.-P. 143−149.
- Dai C.Y., Yu M.L., Chuang W.L. et al. Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan // Nephron. 2002. — Vol. 90 (2). — P. 148−153.
- DaRoza G., Loewen A., Djurdjev O. et al. Stage of chronic kidney disease predicts seroconversion after hepatitis В immunization: earlier is better // Am. J. Kidney Dis. 2003. — Vol. 42 (6). — P. 1184−1192.
- Degos F., Grunfeld J-P. Liver disease and the kidney // In: Oxford Textbook of Clinical Nephrology / Ed. Davison A.M., Cameron J.S., Grunfeld J-P. Oxford, New York, Tokyo: Oxford University Press, 1998. P. 2737−2743.
- Deniz Ayli M., Ensari C., Ayli M. et al. Effect of oral levamisole supplementation to hepatitis В vaccination on the rate of immune response in chronic hemodialysis patients // Nephron. 2000. — Vol. 84 (3). — P. 291−292.
- Dentico P., Buongiorno R., Angarano G. et al. Markers of viral replication (HBeAg and DNA polymerase activity) in chronic uremia, HBsAg positive, hemodialysis patients // Boll. Soc. Ital. Biol. Sper. 1980. — Vol. 56 (21). — P. 2193−2199.
- Department of Health Advisory Group on Hepatitis. Protecting health care workers and patients from hepatitis B. Recommendations of the Advisory Group on Hepatitis. HMSO, 1993. London. — 176 p.
- Descamps-Latscha B. and Chatenoud L. T Cells and В Cells in Chronic Renal Failure // Nephrologie. 1996. — Vol. 16, N 3. — P. 183−191.
- Descamps-Latscha B. Infection and immunity in end-stage renal disease // In: Dialysis / Ed. Henrich W.L. Baltimore, Philadelphia, Hong Kong: Williams & Wilkins, 1994. — P. 209−224.
- Deutsch Т., Carson E., Ludwig E. Dealing with Medical Knowledge. New York and London: Plenum Press, 1994. — 310 p.
- Dilek K., Dilek S., Ersoy A. et al. Factors influencing response to hepatitis В vaccination of haemodialysis patients and timing of additional booster doses // XXXIY-th Congress ERA EDTA, 1997. Geneva. — P. 182.
- Dimkovic N., Dragicevic P., Lazic N., Radmilovic A. Further evidence for nosocomial spread of hepatitis С virus infection in hemodialysis units // Nephron. 1996. — Vol. 74 (2). — P. 488.
- Disney A.P.S. Some trends in chronic renal replacement therapy in Australia and New Zeland 1994 // Nephrol. Dial. Transplant. 1998. — Vol. 13. — P. 854 859.
- Djordjevic V., Stojanovic K., Stojanovic M., Stefanovic V. Prevention of nosocomial transmission of hepatitis С infection in a hemodialysis unit. A prospective study // Int. J. Artif. Organs. 2000. — Vol. 23 (3). — P. 181−188.
- Doumas B.T., Watson W.A., Biggs H.G. Albumin standards and the measurement of serum albumin with bromcresol green // Clin. Chim. Acta. — 1971. — Vol. 31.-P. 87.
- Dueymes J.M., Bodenes-Dueymes M., Mahe J.L., Herman B. Detection of hepatitis В viral DNA by polymerase chain reaction in dialysis patients//Kidney Int. Suppl. 1993.-Vol. 41.-S161-S166.
- Dukes C.S., Street A.C., Starling J.F., Hamilton J.D. Hepatitis В vaccination and booster in predialysis patients: a 4-year analysis // Vaccine. 1993. — Vol. 11(12).-P. 1229−1232.
- Dummin G.J., Couch N.P., Murray J.E. Prolonged survival of skin gomografts in uremic patients // Ann. N.Y. Acad. Sci. 1957. — Vol. 64. — P. 967−976.
- Dusheiko G., Hoofnagle J.H. Infections of the liver // In: Oxford Textbook of Clinical Hepatology / Ed. Mclntyre N., Benhamou J-P., Bircher J., Rizzetto M., Rodes J. Oxford: Oxford University Press, 1991. — P. 571−592.
- Dussol В., Chicheportiche C., Cantaloube J.F. et al. Detection of hepatitis С infection by polymerase chain reaction among hemodialysis patients // Am. J. Kidney Dis. 1993. — Vol. 22 (4). — P. 574−580.
- Dussol В., Berthezene P., Brunet P. et al. Hepatitis С virus infection among chronic dialysis patients in the south of France: a collaborative study // Am. J. Kidney Dis. 1995. — Vol. 25 (3). — P. 399−404.
- Eddleston A. Modern vaccinees: Hepatitis // Lancet. 1990. — Vol. 335. — P. 1142−1145.
- Ehrenstein M.R., O’Keefe T.L., Davies S.L. et al. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response // Proc. Natl. Acad. Sci. USA. 1998. — Vol. 95. — P. 10 891 093.
- El-Reshaid К., Kapoor M., Sugthan T. et al. Hepatitis С virus infection in patients on maintenance dialysis in Kuwait: epidemiological profile and efficacy of prophylaxis // Saudi Med. J. 2003. — Vol. 24 (suppl. 2). — SI34.
- Elwell R.J., Neumann M., Bailie G.R. Factors associated with long-term antibody production induced by hepatitis В vaccine in patients undergoing hemodialysis: a retrospective cohort study // Pharmacotherapy. 2003. — Vol. 23 (12). — P. 1558−1563.
- Elwell R.J., Neumann M., Manley H.J., Carpentier L. Hepatitis В vaccination: addressing a drug-related problem in hemodialysis outpatients with a collaborative initiative // Nephrol. Nurs. J. 2003. — Vol. 30 (3). — P. 310−313.
- Evans T.G., Schiff M., Graves B. et al. The safety and efficacy of GM-CSF as an adjuvant in hepatitis В vaccination of chronic hemodialysis patients who have failed primary vaccination // Clin. Nephrol. — 2000. — Vol. 54 (2). P. 138−142.
- Fabrizi F., Lunghi G., Andrulli S. et al. Influence of hepatitis С virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients // Nephrol. Dial. Transplant. 1997. — Vol. 12. — P. 1394−1398.
- Fabrizi F., Martin P. Hepatitis В virus infection in dialysis patients // Am. J. Nephrol. 2000. — Vol. 20 (1). — P. 1−11.
- Fabrizi F., Bisegna S., Mangano S. et al. Hepatopathy and hepatitis В virus infection in dialysis patients: cross-sectional study // G. Ital. Nefrol. 2002. -Vol. 19 (2).-P. 149−154.
- Fanelli V., Sanna G., Solinas A. Expectation of imparired response to recombinant hepatitiB vaccination // Nephron. 1992. — Vol. 61. — P. 293−295.
- Faranna P., Cozzi G., Belloni M., Pedrini L. Immunization and Vaccination Protocol in Hemodialysis Patients With Naturally Acquired Hepatitis В Antibody//Nephron. 1992.-Vol. 61.-P. 311−312.
- Fashir В., Sivasubramaniam V., Al-Momen S., Assaf H. Hepatitis С virus infection among maintenance hemodialysis patients // Saudi Med. J. — 2003. — Vol. 24 (suppl 2). SI24.
- Favero M.S., Maynard J.E., Petersen N.J. et al. Hepatitis-B antigen on environmental surfaces // Lancet. 1973. — Vol. 302. — P. 1455.
- Feinman S.V., Berris В., Fay O. et al. Serum HBV-DNA (hepatitis В virus DNA) in acute and chronic hepatitis В infection // Clin. Invest. Med. 1988. -Vol. 11 (4).-P. 286−291.
- Fontaine H., Pol S. Prevention and treatment of viral hepatitis in renal insufficiency conditions // Nephrologie. 2001. — Vol. 22 (7). — P. 339−347.
- Froio N., Nicastri E., Comandini U.V. et al. Contamination by hepatitis В and С viruses in the dialysis setting // Am. J. Kidney Dis. 2003. — Vol. 42 (3) -P. 546−50.
- Garson J.A., Brillanti S., Ring C. et al. Hepatitis С viraemia rebound after «successful» interferon therapy in patients with chronic non-A, non-B hepatitis // J. Med. Virol. 1992. — Vol. 37. — P. 210−214.
- Gerez L., Madar L., Shkolnik T. et al. Regulation of interleikin-2 and inter-feron-y gene expression in renal failure // Kidney Int. 1991. — Vol. 40. — P. 266−272.
- Girndt M., Kohler H., Schiedhelm-Weick E. et al. T-cell activation defect in hemodialysis patients: Evidence for a role of the B7/CD28 pathway // Kidney Int. 1993. — Vol. 44. — P. 359−365.
- Girndt M., Trumpfheller C., Hunger F. et al. Reduced expression of B7-molecules on monocytes of hemodialysis patients is involved in impaired T-cell activation // J. Am. Soc. Nephrol. 1994. — Vol. 5. — P. 748.
- Girndt M., Heisel O., Kohler H. Influence of dialysis with polyamide versus hemophane hemodialysis on monokines and complement activation during a four month long term study // Nephrol. Dial. Transplant. 1999. — Vol. 14. — P. 676−682.
- Girndt M., Sester M., Sester U. et al. Defective expression of B7−2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect // Kidney Int. 2001. — Vol. 59. — P. 1382−1389.
- Girndt M., Kohler H. Hepatitis В Virus Infection Hemodialysis Patients // Seminars in Nephrology. 2002. — Vol. 4. — P. 340−350.
- Gonzalez-Griego M., Penton E., Delgado G. et al. Impact of an anti-hepatitis В virus (HBV) immunization program in patients undergoing dialysis in Havana, Cuba // Invest. Clin. 2000. — Vol. 41 (4). — P. 237−244.
- Graeff P.A., Dankert J., Zeeuw D. et al. Immune response to Two Diferrent Hepatitis В Vaccine in Hemodialysis Patients: a 2-year follow-up // Nephron. -1985.-Vol. 40.-P. 155−160.
- Grob P. Hepatitis В vaccination of renal transplant and hemodialysis patients // Scand. J. Infect. Dis. Suppl. 1983. — Vol. 38. — P. 28−32.
- Guh J.Y., Lai Y.H., Yang C.Y. et al. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients // Nephron. 1995. — Vol. 69. — P. 459−465.
- Haddler S., Francis D., Maynard J. et al. Long-term immunogenicity and efficacy of hepatitis В vaccine in homosexyal men // N. Engl. J. med. — 1986. -Vol. 315.-P. 209−214.
- Hadziyannis S.J. Hepatocellular carcinoma and type В hepatitis // Clin, in Gastroenterol. 1980. — Vol. 9. — P. 117−134.
- Hakim R.M., Lazarus J.M. Biochemical parameters in chronic renal failure // Am. J. Kidney Dis. 1988. — Vol. 11. — P. 238−247.
- Hakim R.M., Zaoui P., Green W. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression // Kidney Int. — 1991. Vol. 39. -P. 1020−1026.
- Hall A.J. Hepatitis В vaccination: protection for how long and against what? // Brit. Med. J. 1993. — Vol. 307. — P. 176−177.
- Hassan K., Shternberg L., Alhaj M. et al. The effect of erythropoietin therapy and hemoglobin levels on the immune response to Engerix-B vaccination in chronic kidney disease // Ren. Fail. 2003. — Vol. 25 (3). — P. 471−478.
- Haubitz M., Ehlerding G., Beigel A. et al. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency // Clin. Nephrol. 1996. — Vol. 45. — P. 180−182.
- Haushofer A.C., Hauer R., Brunner H. et al. No evidence of hepatitis В virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis С virus antibody positivity // J. Clin. Virol. 2004. — Vol. 29(4). — P. 221−223.
- Hayashi J., Nakashima K., Yoshimura E. et al. Prevalence and role of hepatitis С viraemia in haemodialysis patients in Japan // J. Infect. 1994. -Vol. 28 (3). — P. 271−277.
- Heaf J.G. Liver function tests and pyridoxine levels in uremia // Nephron. — 1982.- Vol. 30.-P. 131−136.
- Henry J., Miller M.M., Pontaroitti P. Structure and evolution of the extended B7 family // Immunol. Today. 1999. — Vol. 20. — P. 285−288.
- Herrero J.A., Mateos P., Marques M. et al. Hepatitis В vaccination in pre-dialysis patients: analysis of the response with two protocols // XXXVI-th Congress ERA EDTA, 1999. Madrid, Spain. — P. 172.
- Hess G., Massing A., Rossol S. et al. Hepatitis С virus and sexual transmission // Lancet. 1989. — Vol. 334. — P. 987.
- Hess G., Kreiter F., Kosters W., Deusch K. The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hepatitis В vaccination in haemodialysis patients // J. Viral. Hepat. 1996. — Vol. 3. — P. 149−153.
- Hollinger F. Factors influencing the immune response to hepatitis В vaccines. Booster dose guidelinea and vaccine protocol recommendations // Am. J. Med. 1989. — Vol. 87/3A. — S336-S-340.
- Horowitz M.M., Ershler W.B., McKinney W. P, Battiola R.J. Duration of immunity after hepatitis В vaccination: efficacy of low-doe booster vaccine // Ann. Intern. Med. 1988. — Vol. 108 (2). — 185−189.
- Hsu H., Wright Т., Luba D. et al. Failure to detect hepatitis С virus genome in human secretions with the polymerase chain reaction // Hepatology. 1991. -Vol. 14.-P. 763−767.
- Immich H. Mediziniche Statistik. Stuttgart, Germany: Schattaure, 1974. -P. 99.
- Idilman R., De M.N., Colantoni A. et al. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis С // Am. J. Gastroenterol. 2002. — Vol. 97 (2). — 435−439.
- Jadoul M., Goubau P. Is anti-hepatitis В virus (HBV) immunization successful in elderly hemodialysis (HD) patients? // Clin. Nephrol. 2002. — Vol. 58 (4).-P. 301−304.
- Jalava Т., Ranki M., Bengtstrom M. et al. A rapid and quantitative solution hybridization method for detection of HBV DNA in serum // J. Virol. Methods. -1992.-Vol. 36.-P. 171−180.
- Jankovic N., Cala S., Nadinic B. et al. Hepatitis С and hepatitis В virus infection in hemodialysis patients and staff: a two year follow-up. // Int. J. Artif. Organs. 1994. — Vol. 17 (3). — P. 137−140.
- Jha R., Lakhtakia S., Jaleel M.A., Narayan G. et al. Improved seroconversion rate to hepatitis В vaccine in haemodialysis ptients with use of granulocyte macrophage colony stimulating factor // XXXVI-th Congress ERA EDTA, 1999. Madrid, Spain. — P. 17.
- Jibani M.M., Heptonstall J., Walker A.M. et al. Hepatitis В immunization in UK renal units: failure to put policy into practice // Nephrol. Dial. Transplant. — 1994. Vol. 9.-P. 1765−1768.
- Jilg W., Schmidt M., Deinhardt F. Persistence of specific antibodies after hepatitis В vaccination // J. Hepatol. 1988. — Vol. 6 (2). — P. 201−207.
- Jindal K.K., Manuel A., Goldstein M.B. Percent reduction in blood urea concentration during hemodialysis (PRU). A simple and accurate method to estimate Kt/V urea // Transplant. ASAIO. 1987. — Vol. 33. — P. 286−288.
- Jungers P., Devillier P., Salomon H. et al. Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uremic patients who are non-responders to hepatitis В vaccine // Lancet. 1994. — Vol. 344. — P. 856−857.
- Just M., Berger R., Scheiermann N. et al. Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis В vaccine // Vaccine. — 1988.-Vol. 6.-P. 401−402.
- Kahns M., de Medina M., McNamara A. et al. Detection of hepatitis С virus RNA in hemodialysis patients // J. Am. Soc. Nephrol. 1994. — Vol. 4. — P. 1491−1497.
- Kalayci C., Johnson P.J., Davis S.E., Williams R. Hepatitis В virus related hepatocellular carcinoma in the non cirrhotic liver // Hepatology. — 1991. -Vol. 12.-P. 54−59.
- Kamata K., Okubo M., Sada M. Immunosupressive factors in ureamic sera are composed of both dialysable and non-dialysable components // Clin. Exp. Immunol. 1983. — Vol. 54. — P. 277−281.
- Kane M., Banatvala J., van Damme P. et al. On behalf of European Consensus Group on Hepatitis В immunity. Are booster immunisations needed for lifelong hepatitis В immunity? // Lancet. 2000. — Vol. 355. — P. 561−565.
- Kaperonis N., Stavroulaki A., Barbatsi C. et al. Long-term effectiveness of intradermal vs intramuscular vaccination against hepatitis В in hemodialysis patients // XXXVI-th Congress ERA EDTA, 1999. Madrid, Spain. — P. 236.
- Kapoor D., Aggarwal S.R., Singh N.P. et al. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis В virus vaccine in previously unvaccinated hemodialysis patients // J. Viral. Hepat. 1999. Vol. 6. — P. 405−409.
- Katzner K., Kalitzky M., Steinhagen-Thiessen E. et al. Course of antibody titer following preventive hepatitis В vaccination and a recommendation for renewal following the use of H-B-Vax vaccines // Z. Gastroenterol. 1985. -Vol. 23(1).-P. 18−24.
- Kaul H., Girndt M., Sester U. et al. Initiation of hemodialysis treatment leads to improvement of T cell activation in patients with end stage renal diseases // Am. J. Kidney Dis. 2000. — Vol. 5. — P. 611−614.
- Kayatas M., Akalin E., Ozdemir F.N. et al. Levamisole treatment enhances protective // XXXIY-th Congress ERA EDTA, 1997. Geneva. — P. 168.
- Kayatas M. Levamisole treatment enhances protective antibody response to hepatitis В vaccination in hemodialysis patients // Artif. Organs. 2002. — Vol. 26 (6).-P. 492−496.
- Khan A.N., Bernardini J., Rault R.M., Piraino B. Low seroconversion with hepatitis В vaccination in peritoneal dialysis patients // Perit. Dial. Int. 1996. -Vol. 16.-P. 370−373.
- Kher V., Krishnamurthy G. Strategies of vaccination against hepatitis В virus infection in renal failure patienys: When why and how? // Ind. J. Nephrol. -1996.-Vol. 6.-P. 137−141.
- Kitchen A.D., Harrison T.J., Meacock T.J. et al. Incidence and significance of hepatitis В core antibody in a healthy blood donor population // J. Med. Virol.- 1988.-Vol. 25(1).-P. 69−75.
- Knodell R.G., Ishak K.G., Black W.C. et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis // Hepatology. 1981. — Vol. 4. — P. 431.
- Kohler H. Hepatitis В immunisation in dialysis patients is it worthwhile? // Nephrol. Dial. Transplant. 1994. — Vol. 9. — P. 1719−1720.
- Kovacic V., Sain M., Vukman V. et al. Efficient haemodialysis improves the response to hepatitis В virus vaccination // Intervirology. 2002. — Vol. 45 (3). -P. 172−176.
- Kovacic V., Sain M., Vukman V. Hepatitis В vaccination in patients on chronic hemodialysis // Lijec. Vjesn. 2003. — Vol. 125 (5−6). — P. 156−158.
- Krishnamurthy G., Kher V., Naik S. et al. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of В cells // Scand. J. Urol. Nephrol. 2002. — Vol. 36 (5). — P. 377−382.
- Krugman S. The newly licensed hepatitis В vaccine // J. Am. Med. Ass. -1982. Vol. 247. — P. 2012−2015.
- Kuhns M., de Medina M., McNamara A. et al. Detection of hepatitis С virus RNA in hemodialysis patients // J. Am. Soc. Nephrol. 1994. — Vol. 4 (7). — P. 1491−1497.
- Kurz P., Kohler H., Meuer S. et al. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect // Kidney Int. 1986. — Vol. 29.-P. 1209−1213.
- Lai K.N., Tarn J.S., Lai F.M., Lin H.J. Isolated presence of antibody to hepatitis В core antigen in dialysis patients: occurrence of subclinical hepatitis? // Am. J. Kidney Dis. 1989. — Vol. 13 (5). — P. 370−376.
- Lai C.L., Lau J.Y., Yeoh E.K. et al. Significance of isolated anti-HBc sero-positivity by ELISA: implications and the role of radioimmunoassay // J Med. Virol. 1992. — Vol. 36 (3). — P. 180−183.
- Leblebicioglu H., Gunaydin M., Cengiz K., Islek I. Hepatitis markers in hemodialysis patients // Mikrobiyol. Bui. 1993. — Vol. 27 (4). — P. 321−326.
- Li Volti S., Giammanco-Bilancia G., Giammanco G., Mollica F. Duration of hepatitis В antibody response in children immunised with hepatitis В and compulsory vaccines // Eur. J. Epidemiol. 1995. — Vol. 11 (2). — P. 217−219.
- Liu Y., Linsley P. S. Costimulation of T-cell growth // Current Opin. in Immunol. 1992. — Vol. 4. — P. 265−270.
- Liu H.B., Meng Z.D., Ma J.C. et al. A 12-year cohort study on the efficacy of plasma-derived hepatitis В vaccine in rural newborns // World J. Gastroenterol. 2000. — Vol. 6. — P. 381−383.
- Lombardi M., Cerrai Т., Dattolo P. et al. Is the dialysis membrane a safe barrier against HCV infection? // Nephrol. Dial. Transplant. 1995. — Vol. 10. — P. 578−579.
- London W.T., DiFiglia M., Sutnick A.I., Blumberg B.S. An epidemic of hepatitis in a chronic hemodialysis unit // N. Engl. J. Med. 1969. — Vol. 281. -P. 571−578.
- Lonnemann G., Linnenweber S., Burg M. et al. Transfer of endogenous pyrogens across artificial membranes? // Kidney Int. Suppl. 1998. — Vol. 66. — P. 43−46.
- Lopez-Alcorocho J.M., Barril G., Ortiz-Movilla N. et al. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients // J. Med. Virol. 2001. — Vol. 63 (2). — P. 103−107.
- Lowrei E., Laid N.M., Henry R.R. Protocol fore National Cooperative Dialysis Study // Kidney Int. Suppl. 1983. — № 13. — P. SI 1-S19.
- Majdan M., Polz M., Ksiazek A. et al. The response to the hepatitis В virus vaccine in patients undergoing hemodialysis and peritoneal dialysis—personal experience // Przegl. Lek. 1995. — Vol. 52 (6). — P. 307−310.
- Manchini G., Nash D.R., Heremans J.F. Further stadies on single radial immunodiffusion. Quantitative analysis of related and unrelated antigens // Immu-nochemistry. 1970. — Vol. 7. — P. 261−264.
- Manzini P., Amore A., Bonaudo R. et al. Is HCV RNA detectable in the ul-trafiltrate? // Minerva Urol. Nefrol. 1996. — Vol. 48. — P. 75−79.
- Marangi A.L., Giordano R., Montanaro A. et al. Hepatitis В virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination // Am. J. Kidney Dis. 1994. — Vol. 23. — P. 537−542.
- Martinov S., Kugaevskaya A., Kopyrina E. et al. Hepatitis virus infection in haemodialysis patients in Sakha Republic (Yakutia) // XXXVI-th Congress ERA EDTA, 1999. Madrid, Spain. — P. 216.
- McAdam A.J., Schweitzer A.N., Sharpe A.H. The role of B7 costimulation in activation and differentiation of CD4+ and CD8+ T cells // Immunol. Rev. — 1998. — Vol. 165. — P. 231−247.
- Mclntyre A., Nimmo G.R., Wood G.M. et al. Isolated hepatitis В core antibody can response to hepatitis В vaccine help elucidate the cause? // Aust. N.Z. Med. — 1992. — Vol. 22. — P. 19−22.
- McLaughlin K.J., Cameron S.O., Good T. et al. Nosocomial transmission of hepatitis С virus within British dialysis center // Nephrol. Dial. Transplant. -1997.-Vol. 12.-P. 304−309.
- Meuer S.C., Hauer M., Kurz P. et al. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired immune responses // J. Clin. Investig. 1987. — Vol. 80. — P. 743−749.
- Meuer S.C., Dumann H., Meyer zum Buschenfelde K.H., Kohler H. Low-dose interleukin-2 induces systemic immune responses against HBsAg in im-munodeficient non-responders to hepatitis В vaccination // Lancet. 1989. — i. -P. 15−18.
- Mezzelani P., Quaglio G., Venturini L., Lugoboni F. The significance of the isolated anti-HBc carrier. A study of 1797 drug addicts. The Intersert Group of Scientific Collaboration // Recenti Prog. Med. 1994. — Vol. 85(9). — P. 419 424.
- Milkowski A., Wyrwicz G., Kubit P., Smolenski O. Comparison of anti-HBV vaccine efficacy given intradermally and intramuscularly in hemodialysis patients // Przegl. Lek. 2000. — Vol. 57 (11). — P. 628 634.
- Miller E.R., Alter M.J., Tocars J.I. Protective effect of hepatitis В vaccine in chronic hemodialysis patients // Am. J. Kidney Dis. 1999. — Vol. 33 (2). — P. 356−360.
- Mitwalli A. Responsiveness to hepatitis В vaccine in immunocompromised patients by doubling the dose scheduling // Nephron. 1996. — Vol. 73. — P. 417−420.
- Modai D., Berman S., Weissgarten J. et al: Induction of suppressor cell activity in normal peripheral blood mononuclear cells by sera from predialytic uremic patients // Int. Arch. Allergy Appl. Immunol. 1990. — Vol. 92. — P. 268−271.
- Morita Y., Yamamura M., Kashihara N. et al. Increased production of iter-leukin-10 and inflammatory cytokines in blood monocites of hemodialysis patients // Res. Comuiun. Mol. Pathol Pharmacol. 1997. — Vol. 98. — P. 19−33.
- Muller G.Y., Zabaleta M.E., Arminio A. et al. Risk factors for dialysis-associated hepatitis С in Venezuela // Kidney Int. 1992. — Vol. 41. — P. 10 051 008.
- Muszytowski M., Manitius J., Ruszkiewicz-Folda M. et al. Prevalence of response to anti-HBV infection in patients on maintenance hemodialysis infected with hepatitis С virus (HCV) // Przegl. Lek. 1996. — Vol. 53 (5). — P. 417−419.
- Mutreja J., Padma G., Abraham P. et al. Hepatitis В & hepatitis С in ESRD on renal replacement therapy in a tertiary care center in a developing country // XXXVI-th Congress ERA EDTA, 1999. Madrid, Spain. — P. 245.
- Mutreja J., Gibbs R.D., Mulligan M.M. et al. Intradermal hepatitis В virus vaccine: immunogenicity and side-effects in adults // Lancet. 1983. — Vol. 2. -P. 1454−1456.
- Nanji A.A. Decreased activity of commonly measured: cause and clinical significance // Am. J. Med. Technol. 1983. — Vol. 49. — P. 241−245.
- Navarro J.F., Teruel J.L., Mateos M.L. et al. Antibody level after hepatitis В vaccination in hemodialysis patients: influence of hepatitis С virus infection // Am. J. Nephrol. 1996. — Vol. 16. — P. 95−97.
- Neilson J.O., Dietrichson O., Elling P., Christofferson P. Incidence and meaning of persistence of Australian antigen in patients with acute viral hepatitis: development of chronic hepatitis // N. Engl. J. Med. 1971. — Vol. 285. — P. 1157−1159.
- Niu M.T., Coleman P.J., Alter M.J. Multicenter study of hepatitis С virus infection in chronic hemodialysis patients and hemodialysis center staff members // Am. J. Kidney Dis. 1993. — Vol. 22. — P. 568−573.
- Nomiyama K., Tsuji H., Ikeda K. et al. Prevalence of hepatitis С virus antibody in patients on chronic hemodialysis // Fukuoka Igaku Zasshi. 1998. -Vol. 89 (8).-P. 232−237.
- Norusis M.J. SPSSx Advanced Statistics Guide. New York: McGrow-Hill, 1985.-276 p.
- Oguchi H., Miyasaka M., Tokunaga S. et al. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units // Clin. Nephrol. 1992. -Vol. 38.-P. 36−43.
- Olmer M., Bouchouareb D., Zandotti C. et al. Transmission of the hepatitis С virus in hemodialysis unit: evidence for nosocomial infection // Clin. Nephrol. 1997. — Vol. 47. — P. 263−270.
- Omar M.N., Tashkandy M.A. Liver enzyme and protein electrophoretic pattern in hemodialysis patients with antibodies against the hepatitis С virus // Saudi Med. J. 2003. — Vol. 24 (suppl. 2). — SI22.
- Ono K., Kashiwagi S. Complete seroconversion by low-dose intradermal injection of recombinant hepatitis В vaccine in haemodialysis patients // Nephron. -1991.-Vol. 58. P. 47−51.
- Otedo A.E., Mc’Ligeyo S.O., Okoth F.A., Kayima J.K. Seroprevalence of hepatitis В and С in maintenance dialysis in a public hospital in a developing country // Afr. Med. J. 2003. — Vol. 93 (5). — P. 380−384.
- Othman В., Monem F. Prevalence of antibodies to hepatitis С virus among hemodialysis patients in Damascus, Syria // Infection. 2001. — Vol. 29 (5). -P. 262−265.
- Ozdogan M., Ozgur O., Gur G. et al. Histopathological impacts of hepatitis virus infection in hemodialysis patients: should liver biopsy be performed before renal transplantation? // Artif. Organs. 1997. — Vol. 21 (5). — P. 355−358.
- Peces R., de la Torre M., Alcazar R., Urra J.M. Prospective analysis of the factors influencing the anti body response to hepatitis В vaccine in haemodialysis patients // Am. J. Kidney Dis. 1997. — Vol. 29. — P. 239−245.
- Peces R., Laures A.S. Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis В vaccine: role of a booster dose on antibody response // Nephron. 2001. — Vol. 89 (2). — P. 172−176.
- Pereira B.J.G. Hepatitis С infection in patients on dialysis // Semin. Dial. -1994.-Vol. 7.-P. 360−368.
- Pereira B.J.G., Levey A.S. Hepatitis С virus infection in dialysis and renal transplantation // Kidney Int. 1997. — Vol. 51. — P. 981−999.
- Pereversev-Orlov V.S., Stenina I.I., Trunov V.G. Syndrome Analysis of Data // Patter Recognition and image analysis. 1993. — Vol.3, N 4. — P. 500 505.
- Perrillo R.P. Hepatitis В: Transmission and natural history // Gut. 1993. -Vol. 34 (suppl). — S48-S49.
- Pertosa G., Tarantino E.A., Gesualdo L. et al. C5b-9 generation and cytokine production in hemodialyzed patients // Kidney Int. Suppl. 1993. — Vol. 41. -P. 221−225.
- Picciotto A., Varagona G., Gurreri G. et al. Anti-hepatitis С virus antibodies and hepatitis С virus viraemia in haemodialysis patients // Nephrol. Dial. Transplant. 1993. — Vol. 8 (10). — P. 1115−1117.
- Pol S., Debure A., Degott C. et al. Chronic hepatitis in kidney allograft recipients // Lancet. 1990. — Vol. 335. — P. 878−880.
- Pol S., Dubois F., Mattlinger B. et al. Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in France // Transplantation. 1992. — Vol. 54 (6). — P. 1096−1097.
- Pol S., Romeo R., Zins B. et al. Hepatitis С virus RNA in anti-HCV positive hemodialysed patients: significance therapeutic implications // Kidney Int. -1993.-Vol. 44.-P. 1097−1100.
- Propst Т., Propst A., Lhotta K. et al. Reinforced intradermal hepatitis В vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination // Am. J. Kidney Dis. 1998. — Vol. 32 (6).-P. 1041−1045.
- Pru C.E., Cuervo C., Ardila M., Teran M. Hepatitis С transmission through dialysis machines // ASAIO J. 1994. — Vol. 40 (3). — P. 889−891.
- Pujol F.H., Ponce J.G., Lema M.G. et al. High incidence of hepatitis С virus infection in hemodialysis patients in units with high prevalence // J. Clin. Microbiol. 1996. — Vol. 34 (7). — P. 1633−1636.
- Quiroga J.A., Castillo I., Porres J.C. et al. Recombinant gamma-interferon as adjuvant to hepatitis В vaccine in hemodialysis patients // Hepatology. — 1990. Vol. 12 (4 Pt. 1). — P. 661−663.
- Ribot S., Rothstein M., Goldblat M., Grasso M. Duration of hepatitis В surface antigenemia (HBsAg) in hemodialysis patients // Arch. Intern. Med. — 1979.-Vol. 139.-P. 178−180.
- Roll M., Norder H., Magnius L.O. et al. Nosocomial spread of hepatitis В virus (HBV) in a haemodialysis unit confirmed by HBV DNA sequencing // J. Hosp. Infect. 1995. — Vol. 30 (1). — P. 57−63.
- Saab S., Weston S.R., Ly D. et al. Comparison of the cost and effectiveness of two strategies for maintaining hepatitis В immunity in hemodialysis patients // Vaccine. 2002. — Vol. 20 (25−26). — P. 3230−3235.
- Said R.A., Hamzeh Y.Y., Mehyar N.S. et al. Hepatitis С virus infection in hemodialysis patients in Jordan // Saudi Med. J. 2003. — Vol. 24 (suppl. 2). -S137.
- Salako B.L., Ayodele O.E., Kadiri S., Arije A. Prevalence of hepatitis В and С viruses in pre-dialysis patients with chronic renal failure // Afr. J. Med. Sci. -2002. Vol. 31 (4). — P. — 311−314.
- Sampietro M., Badalamenti S., Salvadori S. et al. High prevalence of a rare hepatitis С virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV // Kidney Int. 1995. — 47 (3). — P. 911−917.
- Santana Rodrigues O.E., Morillis Jarillo C., Esparza Martin N. et al. Transient blood surface antigens of hepatitis В in patients on hemodialysis // Rev. Clin. Esp. 1999. — Vol. 199 (4). — P. 198−201.
- Schindler R., Lonnemann G., Schaffer J., et al. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis // Nephron. 1994. — Vol. 68. — P. 229−233.
- Schreiber G.B., Busch M.P., Kleinman S.H., Korelitz J.J. The risk of transfusion transmitted viral infections. The Retrovirus Epidemiology Donor Study // N. Engl. J. Med. — 1996. — Vol. 334. — P. 1685−1690.
- Sezer S., Ozdemir F.N., Guz G. et al. Factors Influencing Response to Hepatitis В Virus Vaccination in Hemodialysis Patients // Transplantation Proceedings. 2000. — Vol. 32. — P. 607−608.
- Sherlock S., Dooley J. Diseases of the liver and biliary system. Oxford, London, Edinburg, Maiden: Blackwell Science Ltd, 1997. — P. 274−335.
- Sherman K.E. Alanine aminotransferase in clinical practice. A review // Arch. Intern. Med. 1991. — Vol. 151. — P. 260−265.
- Shusterman N., Signer I. Infection hepatitis in dialysis patients // Am. J. Kidney Dis. 1987. — Vol. 9. — P. 447−455.
- Simmonds P., Holmes E.C., Cha T.A. et al. Classification of hepatitis С virus into six major region genotypes and a series subtypes by phylgenetic analysis of the NS5 region // J. Gen. Virol. 1993. — Vol. 74. — P. 2391−2399.
- Simmonds P., Alberti A., Alter H.J. A proposed system for the nomenclature of hepatitis С viral genotypes // Hepatology. 1994. — Vol. 19. — P. 13 211 324.
- Simo Minana J., Gaztambide Ganuza M., Fernandez Millan P., Pena Fernandez M. Hepatitis В vaccine immunoresponsiveness in adolescents: a revac-cination proposal after primary vaccination // Vaccine. 1996. — Vol. 14 (2). -P. 103−106.
- Singh N.P., Mandal S.K., Thakur A. et al. Efficacy of GM-CSF as an adjuvant to hepatitis В vaccination in patients with chronic renal failure—results of a prospective, randomized trial // Ren. Fail. 2003. — Vol. 25 (2). — P. 255−266.
- Sivapalasingam S., Malak S.F., Sullivan J.F. et al. High prevalence of hepatitis С infection among patients receiving hemodialysis at an urban dialysis center // Infect. Control. Hosp Epidemiol. 2002. — Vol. 23 (6). — P. 319−324.
- Slade B.A., Vroon D.H. Anti-HBc to screen for susceptibility to hepatitis B. // Lancet. 1984. — Vol. 1 — P. 1246−1247.
- Soborg M., Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity // Acta Med. Scand. 1967. — Vol. 181. — P. 247−256.
- Spanish multicentere study group, coordinators Barril G., Traver J.A. Prevalence of hepatitis С virus in dialysis patients in Spain // Nephrol. Dial. Transplant. 1995. — Vol. 10 (suppl. 6). — P. 78−80.
- Stevens C.E., Szmuness W., Goodman A.I. et al. Hepatitis В vaccine: immune responses in haemodialysis patients // Lancet. 1980. — ii. — P. 12 111 213.
- Stevens C.E., Alter H.J., Taylor P.E. et al. Hepatitis В vaccine in patients receiving hemodialysis. Immunogenicity and efficacy // N. Engl. J. Med. 1984. -Vol.311,№ 8.-P. 496−501.
- Stuyver L., Claeys H., Wyseur A. et al. Hepatitis С virus in hemodailysis unit: molecular evidence for nosocomial transmission // Kidney Int. 1996. — Vol. 49.-P. 889−895.
- Sudhagar K., Chandrasekar S., Rao M.S., Ravichandran R. Effect of granulocyte macrophage colony stimulating factor on hepatitis-B vaccination in haemodialysis patients // J. Assoc. Physicians India. — 1999. — Vol. 47 (6).-P. 602−604.
- Sunder-Plassman G., Heinz G., Wagner L. et al. T-cell selection and T-cell receptor variabl beta-chain usage in chronic hemodialysis patients // Clin. Nephrol. 1992. — Vol. 37, № 5. — P. 252−259.
- Szmuness W., Harley E.J., Ikran H. et al. Sociodemographic aspects of hepatitis В // In: Viral Hepatitis. Philadelphia: Franklin Institute Press, 1978. -P. 297−320.
- Szmuness W., Stevens C.E., Harley E.J. et al. Hepatitis В vaccine: demonstration of efficacy in controlled clinical trial in a high-risk population in the United States // N. Engl. J. Med. 1980. — Vol. 303. — P. 833−841.
- Szmuness W., Stevens C.E., Harley E.J. et al. Hepatitis В vaccine in medical staff of hemodialysis units efficacy and subtype cross-protection // N. Engl. J. med. 1982. — Vol. 397. — P. 1481−1486.
- Taal M.W., van Zyl-Smit R. et al. Cost-effectiveness of hepatitis В vaccination in haemodialysis patients // S. Afr. Med. J. 2001. — Vol. 91 (4). — P. 340 344.
- Tabor E., Hoofnagle J.H., Barker L.F. et al. Antibody to hepatitis В core antigen in blood donors with a history of hepatitis // Transfusion. — 1981. Vol. 21.-P. 366−371.
- Talke H., Schubert G.E. Enzymatische harnstoffbestimmung im blut und serum im optischen test nach warburg // Klin. Wschr. 1965. — Vol. 43. — P. 174−175.
- Tamura I., Kobayashi Y., Koda T. et al. Hepatitis С virus antibody in hemodialysis patients // Lancet. 1990. — Vol. 335. — P. 1409.
- Taskapan H., Oymak O., Dogukan A., Utas C. Patient to patient transmission of hepatitis С virus in hemodialysis units // Clin. Nephrol. 2001. — Vol. 55 (6).- P. 477−481.
- Teder R., Gilson R., Briggs M. et al. Hepatitis С virus: evidence for sexual transmission // Brit. Med. J. 1991. — Vol. 302. — P. 1299−1302.
- Teles S.A., Martins R.M., Silva S.A. et al. Hepatitis В virus infection profile in central Brazilian hemodialysis population // Rev. Inst. Med. Trop. San Paulo. 1998. — Vol. 40(5). — P. 281−286.
- Tokars J.I., Arduino M.J., Alter M.J. et al. Infection control in hemodialysis units // Infect. Dis. Clin. North Am. 2001. — Vol. 15 (3). — P. 797−812.
- Tokars J.I., Frank M., Alter M.J., Arduino M.J. National surveillance of dialysis-associated diseases in the United States, 2000 // Semin. Dial. 2002. -Vol. 15(3).-P. 162−71.
- Tremolada F., Casarin C., Alberti A. et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis // Hepatology. 1992. — Vol. 16. — P. 273−281.
- Tron F., Degos F., Brochot C. et al. Randomized dose range study of a recombinant hepatitis В vaccine produced in mammlian cells and containing the S and preS2 sequence // J infect. Dis. 1989. — Vol. 160. — P. 199−204.
- Urbanowicz W. Efficacy of prophylactic vaccination against Hepatitis В Virus infection viruses in hemodialyzed patients // Przegl. Epidemiol. 2000. -Vol. 54 (3−4).-P. 343−350.
- Valderrabano F., Jones E.H.P., Mallick N.P. Report on the management of renal failure in Europe // Nephrol. Dial. Transplant. 1995. — Vol. 10. — P. 125.
- Van Herck K., Van Damme P., Thoelen S., Meheus A. Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis В vaccine: 8-year results // Vaccine. — 1998. — Vol. 16 (20).-P. 1933−1935.
- Vladutiu D-S, Cosa A., Neamtu A. et al. Infections with hepatitis В and С viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? // J. Viral. Hepat. — 2000. Vol. 7 (4).-P. 313−319.
- Vlassopoulos D., Arvanitis D., Lilis D. et al. Complete success of intradermal vaccination against hepatitis В in advanced chronic renal failure and hemodialysis patients // Ren. Fail. 1997. — Vol. 19. — P. 455−460.
- Vlassopoulos D., Arvanitis D., Lilis D. et al. Hepatitis D vaccination in ESRD. 8 year follow up. Factors involved in the immune response // XXXVI-th Congress ERA EDTA, 1999. Madrid, Spain. — P. 150.
- Vlassopoulos D. Recombinant hepatitis В vaccination in renal failure patients // Curr. Pharm. Biotechnol. 2003. — Vol. 4 (2). — P. 141−151.
- Vurusic В., Heinrich В., Grahovac B. et al. Hepatitis viruses coinfection in patients undergoing hemodialysis (HD) // XXXVI-th Congress ERA EDTA, 1999. Madrid, Spain. — P. 275.
- West D.J., Calandra G.B., Ellis R.W. Vaccination of infants and children against hepatitis В // Pediatr. Clin. North Am. 1989. — Vol. 37. — P. 185−601.
- Wiese M., Stradtmann H. Viral hepatitis as a nosocomial infection at the dialysis center: a current 5-year study // Z. Gesamte Hyg. 1986. — Vol. 32 (10).-P. 607−610.
- Wilson W.E.C., Kirkpatrick C.H.H., Talmadge D.W. Suppression of immunologic responsiveness in uremia // Ann. Intern. Med. 1965. — Vol. 62. — P. 1−8.
- Wolf P.L., Williams D., Coplon N., Coulson A.S. Low aspartate transaminase activity in serum of patients undergoing chronic hemodialysis // Clin. Chem. 1972. — Vol. 18. — P. 567−568.
- Wright T.L., Lau J.Y. Clinical aspects of hepatitis В virus infection // Lancet. 1993. — Vol. 342. — P. 1340−1344.
- Yamaji K., Hayashi J., Kawakami Y. et al. Long term survey of hepatitis С virus infection in hemodialysis units in Fukuoka, Japan // J. Epidemiol. 1996. -Vol. 6.-P. 166−171.
- Yang C.S., Chang H.H., Chou C.C., Peng S.J. Isolation effectively prevents the transmission of hepatitis С virus in the hemodialysis unit // J. Formos. Med Assoc. 2003. — Vol. 102 (2). — P. 79−85.
- Yasuda K., Okuda K., Endo N. et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal // Gastroenterology. 1995. — Vol. 109 (4). — P. 1295−1300.
- Yoshioka K., Kakumu S., Wakita T. et al. Detection of hepatitis С virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotypes of hepatitis С virus // Hepatology. 1992. — Vol. 16. — P. 293−299.
- Zacks S.L., Fried M.W. Hepatitis В and С and renal failure // Infect. Dis. Clin. North Am. 2001. — Vol. 15 (3). — P. 877−899.
- Zanetti A., Tanzi E., Paccagnini S. et al. Mother-to-infant transmission of hepatitis С virus // Lancet. 1995. — Vol. 345. — P. 289−291.
- Zannolli R., Morgese G. Hepatitis В vaccine: current issues // Ann. Phar-macother. 1997. — Vol. 31 (9). — P. 1059−1067.
- Zekri A.R., Awlia A.A., El Mahalawi H. et al. Evaluation of blood units with isolated anti HBC for the presence of HBV DNA // Dis. Markers. 2002. -Vol. 18(3).-P. 107−110.
- Ziginskiene E., Kuzminskis V., Kupcinskas L., Stankuviene A. Control of viral hepatitis in Lithuanian hemodialysis centers in 1997−2001 // Medicina (Kaunas). 2003. — Vol. 39 (suppl. 1). — P. 143−149.
- Zoulek G., Lorbeer В., Jilg W., Deinhardt F. Evaluation of a reduced dose of hepatitis В vaccine administered intradermally // J. Med. Virol. 1984. — Vol. 14.-P. 27−38.
- Zuckerman J.N. Hepatitis В third-generation vaccines: improved response and conventional vaccine non-response third generation pre-S/S vaccines overcome non-response // J. Viral. Hepat. — 1997. — Vol. 5. — P. 13−15.